Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors

Rhea-AI Summary

Agilent Technologies (NYSE: A) announced that Hans E. Bishop, co-founder of Altos Labs, has stepped down from the board of directors. Bishop joined the board in July 2017 and has contributed significantly to Agilent’s life sciences initiatives. Chairman Koh Boon Hwee expressed gratitude for Bishop's service. Despite stepping down, Bishop will continue to informally advise Agilent and CEO Padraig McDonnell. Bishop cited other commitments as the reason for his departure but remains optimistic about Agilent’s future under McDonnell’s leadership.

Positive

• Hans E. Bishop's extensive experience in life sciences contributed significantly to Agilent for seven years.
• Bishop will continue to provide informal advisory support to Agilent, ensuring his expertise remains accessible.
• Chairman Koh Boon Hwee expressed positive sentiments regarding Bishop's impactful contributions.

Negative

• Hans E. Bishop's departure from the board might be seen as a loss of valuable leadership and experience.
• The reason for stepping down is due to unspecified 'other commitments,' which could raise concerns about potential conflicts or overextension.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that Hans E. Bishop, president and co-founder of Altos Labs, has stepped down from serving on Agilent’s board of directors.

Bishop joined Agilent’s board in July 2017, after holding a range of leadership positions in the pharmaceutical industry. “Hans’ extensive life science industry leadership and insight have been of great value to the board. We are grateful for his contributions over the past seven years and wish him all the best,” said Koh Boon Hwee, chairman of the board.

Bishop will continue advising Agilent and CEO Padraig McDonnell in an informal capacity. “While I regret having to step away from the board due to other commitments, I am excited about and confident in Agilent’s future under Padraig’s leadership,” said Bishop. “Agilent’s role in enhancing the efficiency and innovation of pharma and biotech companies has become even more essential in this era of rich scientific discovery.”

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521379485/en/

Media Contact:

Tom Beermann

Agilent Technologies

+1 408-386-5892

tom.beermann@agilent.com

Source: Agilent Technologies Inc.

FAQ

Why did Hans E. Bishop step down from Agilent's board of directors?

Hans E. Bishop stepped down due to other commitments.

When did Hans E. Bishop join Agilent's board of directors?

Hans E. Bishop joined Agilent's board in July 2017.

Will Hans E. Bishop continue to be involved with Agilent after stepping down?

Yes, Hans E. Bishop will continue to advise Agilent and CEO Padraig McDonnell informally.

What impact did Hans E. Bishop have on Agilent?

Hans E. Bishop provided significant leadership and insights in the life sciences sector, contributing greatly to Agilent.